Related Experiment Video
Updated: Jun 27, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
[Polyneuropathies in the elderly. Classification and thematic review]
José Manuel Pardal Fernández1, Pedro Abizanda-Soler
1Servicio de Neurofisiología Clínica, Complejo Hospitalario Universitario Albacete, Albacete, Spain.
Revista Espanola De Geriatria Y Gerontologia
|December 17, 2008
Summary
Polyneuropathy (PNP) affects 5-10% of the elderly, often due to diabetes. This article reviews common PNPs in older adults, aiding geriatricians in diagnosis and classification.
Area of Science:
- Neurology
- Geriatrics
Context:
- Polyneuropathy (PNP) affects peripheral nerves, impacting 5-10% of the elderly population.
- Diabetes is the leading cause, though trauma and other pathologies contribute.
- PNP presents diverse symptoms, from sensory/motor deficits to gait instability, complicating diagnosis in older adults.
Purpose:
- To describe common polyneuropathies in the elderly.
- To discuss the physiopathology of these conditions.
- To propose a practical clinical classification for geriatricians.
Summary:
- This review focuses on the main types of polyneuropathy (PNP) prevalent in the elderly.
- It details the underlying physiopathology and diagnostic challenges, particularly for geriatricians.
- Electrophysiology is highlighted as the gold standard for diagnosis.
Impact:
- Aids geriatricians in diagnosing and classifying polyneuropathy in elderly patients.
- Enhances understanding of PNP physiopathology in an aging population.
- Provides a practical framework for managing this common condition in the elderly.
Related Concept Videos
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...